LIGAND PHARMACEUTICALS (LGND) Institutional Shareholders

LIGAND PHARMACEUTICALS (LGND) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $6.59B in LGND holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of LGND tracked by InsiderSet, reporting ownership valued at approximately $980.19M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $904.78M, representing an estimated loss of -7.69% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed LGND value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Invesco Ltd., Vanguard Portfolio Management Llc, and several other long-term asset managers with concentrated positions in LIGAND PHARMACEUTICALS (LGND).

This page ranks the largest institutional LGND shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

407

Total Reported Value

$6.59B

Largest Holder

Blackrock, Inc.

Largest Position

$980.19M

Insider Transactions (90d)

50

Latest Filing Quarter

Q2 2026

New Institutional Positions

72

Funds Exiting Positions

0

Page 1 of 9
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.01%3,100,996$980,193,825$904,777,603-$75,416,222-7.69%
Invesco Ltd.0.03%1,201,644$379,827,651$350,603,670-$29,223,981-7.69%
Vanguard Portfolio Management Llc0.02%1,138,316$359,810,304$332,126,459-$27,683,845-7.69%
Vanguard Capital Management Llc0.01%870,950$275,298,586$254,117,081-$21,181,505-7.69%
State Street Corp0.01%826,539$261,251,813$241,159,284-$20,092,529-7.69%
Fmr Llc0.01%762,827$241,122,115$222,570,034-$18,552,081-7.69%
Congress Asset Management Co1.28%659,911$208,591,268$192,542,232-$16,049,036-7.69%
Janus Henderson Group Plc0.10%1,009,891$201,622,937$294,655,897+$93,032,960+46.14%
Geode Capital Management, Llc0.01%589,020$186,213,020$171,858,365-$14,354,655-7.71%
Nomura Asset Management International Inc.0.27%568,371$179,656,000$165,833,607-$13,822,393-7.69%
Chicago Capital, Llc4.21%553,435$174,935,212$161,475,730-$13,459,482-7.69%
Stephens Investment Management Group Llc1.61%475,609$150,335,249$138,768,438-$11,566,811-7.69%
Dimensional Fund Advisors Lp0.02%429,314$135,699,871$125,260,946-$10,438,925-7.69%
Massachusetts Financial Services Co0.04%375,762$118,774,611$109,636,079-$9,138,532-7.69%
Goldman Sachs Group Inc0.01%323,245$102,174,511$94,313,194-$7,861,317-7.69%
Loomis Sayles & Co L P0.12%291,805$92,236,642$85,139,945-$7,096,697-7.69%
Rice Hall James & Associates, Llc4.15%270,052$85,360,737$78,793,072-$6,567,665-7.69%
Ranger Investment Management, L.P.5.15%257,596$81,423,520$75,158,785-$6,264,735-7.69%
Northern Trust Corp0.01%257,389$81,358,089$75,098,389-$6,259,700-7.69%
Victory Capital Management Inc0.04%253,764$80,212,263$74,040,722-$6,171,541-7.69%
Deutsche Bank Ag\0.02%249,611$78,899,541$72,829,001-$6,070,540-7.69%
Neuberger Berman Group Llc0.05%248,355$78,502,532$72,462,538-$6,039,994-7.69%
Morgan Stanley0.00%200,699$63,439,444$58,557,947-$4,881,497-7.69%
Next Century Growth Investors Llc3.33%198,542$62,757,140$57,928,599-$4,828,541-7.69%
Charles Schwab Investment Management Inc0.01%193,238$61,080,599$56,381,051-$4,699,548-7.69%
Sixth Street Partners Management Company, L.P.0.01%193,238$61,080,599$56,381,051-$4,699,548-7.69%
Aberdeen Group Plc0.08%172,480$54,519,204$50,324,490-$4,194,714-7.69%
Bank Of America Corp0.00%170,349$53,845,507$49,702,728-$4,142,779-7.69%
Private Capital Management, Llc4.76%166,016$52,475,997$48,438,488-$4,037,509-7.69%
Villere St Denis J & Co Llc5.87%155,506$49,153,891$45,371,986-$3,781,905-7.69%
Granahan Investment Management, Llc1.66%147,231$46,538,247$42,957,589-$3,580,658-7.69%
Vanguard Fiduciary Trust Co0.01%142,926$45,177,479$41,701,519-$3,475,960-7.69%
New York State Common Retirement Fund0.05%137,258$43,385,881$40,047,767-$3,338,114-7.69%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.01%212,888$42,503,090$62,114,332+$19,611,242+46.14%
Ashford Capital Management Inc5.12%207,565$41,440,352$60,561,240+$19,120,888+46.14%
Bank Of New York Mellon Corp0.01%131,068$41,429,372$38,241,710-$3,187,662-7.69%
Impax Asset Management Group Plc0.27%130,000$41,091,700$37,930,100-$3,161,600-7.69%
Voya Investment Management Llc0.03%127,071$40,165,872$37,075,506-$3,090,366-7.69%
Ubs Group Ag0.01%124,674$39,408,205$36,376,133-$3,032,072-7.69%
Fisher Asset Management, Llc0.01%121,440$38,386,026$35,432,549-$2,953,477-7.69%
Russell Investments Group, Ltd.0.03%120,304$38,027,274$35,101,098-$2,926,176-7.69%
Royal Bank Of Canada0.01%119,073$37,638,000$34,741,929-$2,896,071-7.69%
Driehaus Capital Management Llc0.22%118,497$37,455,717$34,573,870-$2,881,847-7.69%
Penn Capital Management Company, Llc2.01%100,337$31,748,435$29,275,326-$2,473,109-7.79%
Legal & General Group Plc0.01%98,746$31,212,622$28,811,120-$2,401,502-7.69%
Principal Financial Group Inc0.02%97,971$30,967,653$28,584,999-$2,382,654-7.69%
Bnp Paribas Financial Markets0.02%94,072$29,735,218$27,447,387-$2,287,831-7.69%
First Trust Advisors Lp0.02%90,893$28,730,368$26,519,851-$2,210,517-7.69%
Osaic Holdings, Inc.0.03%90,236$28,522,521$26,328,158-$2,194,363-7.69%
Sei Investments Co0.03%89,672$28,344,375$26,163,599-$2,180,776-7.69%

Frequently asked questions about LGND

  • Who owns the most LGND stock?

    The largest holders of LGND are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LIGAND PHARMACEUTICALS (LGND).

  • Is LGND widely held by superinvestors?

    Many widely followed stocks like LGND appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LGND is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.